Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124928155 | 12492815 | 5 | F | 20160801 | 20160623 | 20160811 | EXP | IT-TEVA-665195ISR | TEVA | MELE AA, BILANCIO G, LUCIANI R, BELLIZZI V, PALLADINO G. [ATYPICAL MYCOBACTERIAL INFECTION AFTER KIDNEY TRANSPLANT: TWO CLINICAL CASES]. [ITALIAN]. G-ITAL-NEFROL 2013;30:NO. 1. | 30.00 | YR | M | Y | 0.00000 | 20160811 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124928155 | 12492815 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | 1000 MILLIGRAM DAILY; | U | 65154 | 1000 | MG | QD | ||||||
| 124928155 | 12492815 | 2 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | 500 MILLIGRAM DAILY; | U | 65154 | 500 | MG | QD | ||||||
| 124928155 | 12492815 | 3 | I | everolimus | EVEROLIMUS | 1 | Unknown | .75 MILLIGRAM DAILY; | U | 0 | .75 | MG | QD | ||||||
| 124928155 | 12492815 | 4 | I | everolimus | EVEROLIMUS | 1 | Unknown | .5 DAILY; | U | 0 | QD | ||||||||
| 124928155 | 12492815 | 5 | I | rifampicin | RIFAMPIN | 1 | Unknown | 600 MILLIGRAM DAILY; | U | 0 | 600 | MG | QD | ||||||
| 124928155 | 12492815 | 6 | I | rifampicin | RIFAMPIN | 1 | U | 0 | |||||||||||
| 124928155 | 12492815 | 7 | I | ETHAMBUTOL | ETHAMBUTOL HYDROCHLORIDE | 1 | Unknown | 1200 MILLIGRAM DAILY; | U | 0 | 1200 | MG | QD | ||||||
| 124928155 | 12492815 | 8 | I | ETHAMBUTOL | ETHAMBUTOL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124928155 | 12492815 | 9 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | 100 MILLIGRAM DAILY; | U | 0 | 100 | MG | QD | ||||||
| 124928155 | 12492815 | 10 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | 225 MILLIGRAM DAILY; | U | 0 | 225 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124928155 | 12492815 | 1 | Mycobacterium chelonae infection |
| 124928155 | 12492815 | 2 | Immunosuppressant drug therapy |
| 124928155 | 12492815 | 3 | Immunosuppressant drug therapy |
| 124928155 | 12492815 | 5 | Mycobacterium chelonae infection |
| 124928155 | 12492815 | 6 | Atypical mycobacterial infection |
| 124928155 | 12492815 | 7 | Mycobacterium chelonae infection |
| 124928155 | 12492815 | 8 | Immunosuppressant drug therapy |
| 124928155 | 12492815 | 9 | Immunosuppressant drug therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124928155 | 12492815 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124928155 | 12492815 | Atypical mycobacterial infection | |
| 124928155 | 12492815 | Drug interaction | |
| 124928155 | 12492815 | Drug level decreased | |
| 124928155 | 12492815 | Drug level increased | |
| 124928155 | 12492815 | Nausea | |
| 124928155 | 12492815 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |